Investor Relations

News Releases

 
News Releases
  Date Title View
Feb 15, 2017
Worldwide Orthobiologics Revenue Increases 13% Year-over-Year for Fourth Quarter of 2016 Product Revenue Grows 17% for Full Year of 2016 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines comp...
Feb 1, 2017
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter 2016 financial results after the close of the market on Wednesday, February 15, 2017 and to hold a conference call the next day, Thursday, February 16, 2017, at 9:0...
Dec 19, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid "HA" technology, today announced that it received CE Mark approval for ORTHOVISC-T (sodium hyaluronate for pe...
Nov 15, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced that its Chief Financial Officer, Sylvia Cheung, will make a presentation a...
Oct 26, 2016
Worldwide Orthobiologics Revenue Increases 10% Year-over-Year Diluted Earnings Per Share Increases to $0.59 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based...
Oct 12, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its third-quarter 2016 financial results after the close of the market on Wednesday, October 26, 2016 and to hold a conference call the next day, Thursday, October 27, 2016, at 9:00 a...
Sep 22, 2016
-- Podium Sessions Showcase Studies Comparing HYALOFAST versus Collagen Scaffold and Microfracture Surgery for Cartilage Repair -- BEDFORD, Mass. & NAPLES, Italy--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializ...
Aug 25, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced that its Chief Financial Officer, Sylvia Cheung, will participate in the fo...
Jul 27, 2016
Total Revenue Increases 16% Year-over-Year BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today reported financial r...
Jul 13, 2016
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2016 financial results after the close of the market on Wednesday, July 27, 2016 and to hold a conference call the next day, Thursday, July 28, 2016, at 9:00 a.m. E...

= add release to Briefcase